/
RSS Feed
Dr. Whitley talks with Dr. Bobby Azamian, co-founder, president and CEO of Tarsus Pharmaceuticals, about a topic that we haven’t addressed before on the Dry Eye Coach Podcast, which is addressing an unmet need for 25 million Americans: Demodex blepharitis.
Tarsus is developing TP-03, which is a drug that has the potential to be the first FDA approved treatment for Demodex Blepharitis.
Click Here to read the transcript of this podcast.
